首页> 外文OA文献 >Simultaneous Quantitative Determination of Metoprolol, Atorvastatin and Ramipril in Capsules by a Validated Stability-Indicating RP-UPLC Method
【2h】

Simultaneous Quantitative Determination of Metoprolol, Atorvastatin and Ramipril in Capsules by a Validated Stability-Indicating RP-UPLC Method

机译:经验证的稳定性指示RP-UPLC方法同时定量测定胶囊中的美托洛尔,阿托伐他汀和雷米普利

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A simple ultra performance liquid chromatographic (UPLC) method has been developed for the simultaneous estimation of Metoprolol (MT), Atorvastatin (AT) and Ramipril (RM) from capsule dosage form. The method was developed using Zorbax® XDB-C18 (4.6 mm × 50 mm, 1.8 μm) column with a mobile phase consisting of 0.06% ortho phosphoric acid in Milli Q® water having an ion pair reagent, 0.0045 M Sodium lauryl sulphate as buffer, at ratio of buffer: Acetonitrile (50:50 v/v), at 55°C column temperature with a flow rate of 1.0 ml/min. Detection was carried out with ultra-violet detection at 210 nm for RM, MT and AT respectively. The retention times were about 1.3, 2.1 and 2.6 min for MT, AT and RM respectively, the method was validated for linearity, accuracy, precision, specificity, robustness and ruggedness. The % mean recoveries are 101.9, 102.1 and 101.4 for MT, AT and RM respectively. The method was found to be rugged and robust and can be successfully used to determine the three drugs and its combinations.
机译:已经开发了一种简单的超高效液相色谱(UPLC)方法,用于从胶囊剂型中同时估算美托洛尔(MT),阿托伐他汀(AT)和雷米普利(RM)。该方法是使用Zorbax®XDB-C18(4.6 mm×50 mm,1.8μm)色谱柱开发的,该色谱柱的流动相由MilliQ®水中的0.06%正磷酸组成,具有离子对试剂,0.0045 M月桂基硫酸钠作为缓冲液在缓冲液:乙腈(50:50 v / v)的比率下,在55°C柱温下,流速为1.0 ml / min。用210 nm的紫外线分别对RM,MT和AT进行检测。 MT,AT和RM的保留时间分别约为1.3、2.1和2.6分钟,该方法的线性,准确性,精密度,特异性,鲁棒性和耐用性均得到验证。 MT,AT和RM的平均回收率分别为101.9、102.1和101.4。发现该方法坚固耐用,可成功用于确定这三种药物及其组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号